Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jun;84(12):1648–1655. doi: 10.1054/bjoc.2001.1834

Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation

B S Islam-Ali 1, M J Tisdale 1
PMCID: PMC2363694  PMID: 11401319

Abstract

Treatment of murine myoblasts, myotubes and tumour cells with a tumour-produced lipid mobilizing factor (LMF), caused a concentration-dependent stimulation of protein synthesis, within a 24 h period. There was no effect on cell number or [3H] thymidine incorporation, but a similar concentration-dependent stimulation of 2-deoxyglucose uptake. LMF produced an increase in intracellular cyclic AMP levels, which was linearly (r2= 0.973) related to the increase in protein synthesis. The effect of LMF was attenuated by the adenylate cyclase inhibitor MDL 12330A, and was additive with the stimulation produced by forskolin. Both propranolol (10 μM) and the specific β3-adrenergic receptor antagonist SR 59230A (10–5M), significantly reduced the stimulation of protein synthesis induced by LMF. Protein synthesis was also increased by 69% (P = 0.006) in soleus muscles of mice administered LMF, while there was a 26% decrease in protein degradation (P = 0.03). While LMF had no effect on the lysosomal enzymes, cathepsins B and L, there was a decrease in proteasome activity, as determined both by the ‘chymotrypsin-like’ enzyme activity, as well as expression of proteasome α-type subunits, determined by Western blotting. These results show that in addition to its lipid-mobilizing activity LMF also increases protein accumulation in skeletal muscle both by an increase in protein synthesis and a decrease in protein catabolism. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: lipid mobilizing factor, protein synthesis, cyclic AMP, β-adrenergic receptor

Full Text

The Full Text of this article is available as a PDF (119.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson P. T., Helferich W. G., Parkhill L. C., Merkel R. A., Bergen W. G. Ractopamine increases total and myofibrillar protein synthesis in cultured rat myotubes. J Nutr. 1990 Dec;120(12):1677–1683. doi: 10.1093/jn/120.12.1677. [DOI] [PubMed] [Google Scholar]
  2. Bell A. W., Bauman D. E., Beermann D. H., Harrell R. J. Nutrition, development and efficacy of growth modifiers in livestock species. J Nutr. 1998 Feb;128(2 Suppl):360S–363S. doi: 10.1093/jn/128.2.360S. [DOI] [PubMed] [Google Scholar]
  3. Davis R. J. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993 Jul 15;268(20):14553–14556. [PubMed] [Google Scholar]
  4. Faure M., Voyno-Yasenetskaya T. A., Bourne H. R. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem. 1994 Mar 18;269(11):7851–7854. [PubMed] [Google Scholar]
  5. Frödin M., Peraldi P., Van Obberghen E. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem. 1994 Feb 25;269(8):6207–6214. [PubMed] [Google Scholar]
  6. Grant A. L., Helferich W. G., Merkel R. A., Bergen W. G. Effects of phenethanolamines and propranolol on the proliferation of cultured chick breast muscle satellite cells. J Anim Sci. 1990 Mar;68(3):652–658. doi: 10.2527/1990.683652x. [DOI] [PubMed] [Google Scholar]
  7. Groundwater P., Beck S. A., Barton C., Adamson C., Ferrier I. N., Tisdale M. J. Alteration of serum and urinary lipolytic activity with weight loss in cachectic cancer patients. Br J Cancer. 1990 Nov;62(5):816–821. doi: 10.1038/bjc.1990.384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Habener J. F. Cyclic AMP response element binding proteins: a cornucopia of transcription factors. Mol Endocrinol. 1990 Aug;4(8):1087–1094. doi: 10.1210/mend-4-8-1087. [DOI] [PubMed] [Google Scholar]
  9. Hirai K., Hussey H. J., Barber M. D., Price S. A., Tisdale M. J. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res. 1998 Jun 1;58(11):2359–2365. [PubMed] [Google Scholar]
  10. Khan S., Tisdale M. J. Catabolism of adipose tissue by a tumour-produced lipid-mobilising factor. Int J Cancer. 1999 Jan 29;80(3):444–447. doi: 10.1002/(sici)1097-0215(19990129)80:3<444::aid-ijc18>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  11. Kimball S. R., Horetsky R. L., Jefferson L. S. Signal transduction pathways involved in the regulation of protein synthesis by insulin in L6 myoblasts. Am J Physiol. 1998 Jan;274(1 Pt 1):C221–C228. doi: 10.1152/ajpcell.1998.274.1.C221. [DOI] [PubMed] [Google Scholar]
  12. Li J., Adrian T. E. A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. Biochem Biophys Res Commun. 1999 Jul 14;260(3):626–633. doi: 10.1006/bbrc.1999.0955. [DOI] [PubMed] [Google Scholar]
  13. Lorite M. J., Cariuk P., Tisdale M. J. Induction of muscle protein degradation by a tumour factor. Br J Cancer. 1997;76(8):1035–1040. doi: 10.1038/bjc.1997.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lorite M. J., Thompson M. G., Drake J. L., Carling G., Tisdale M. J. Mechanism of muscle protein degradation induced by a cancer cachectic factor. Br J Cancer. 1998 Oct;78(7):850–856. doi: 10.1038/bjc.1998.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McMillan D. N., Noble B. S., Maltin C. A. The effect of the beta-adrenergic agonist clenbuterol on growth and protein metabolism in rat muscle cell cultures. J Anim Sci. 1992 Oct;70(10):3014–3023. doi: 10.2527/1992.70103014x. [DOI] [PubMed] [Google Scholar]
  16. Mersmann H. J. Overview of the effects of beta-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci. 1998 Jan;76(1):160–172. doi: 10.2527/1998.761160x. [DOI] [PubMed] [Google Scholar]
  17. Nisoli E., Tonello C., Landi M., Carruba M. O. Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol. 1996 Jan;49(1):7–14. [PubMed] [Google Scholar]
  18. Orino E., Tanaka K., Tamura T., Sone S., Ogura T., Ichihara A. ATP-dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett. 1991 Jun 24;284(2):206–210. doi: 10.1016/0014-5793(91)80686-w. [DOI] [PubMed] [Google Scholar]
  19. Smith K. L., Tisdale M. J. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer. 1993 Apr;67(4):680–685. doi: 10.1038/bjc.1993.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Southorn B. G., Palmer R. M. Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts. Biochem J. 1990 Sep 15;270(3):737–739. doi: 10.1042/bj2700737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stefanovic D., Erikson E., Pike L. J., Maller J. L. Activation of a ribosomal protein S6 protein kinase in Xenopus oocytes by insulin and insulin-receptor kinase. EMBO J. 1986 Jan;5(1):157–160. doi: 10.1002/j.1460-2075.1986.tb04190.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sturgill T. W., Wu J. Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6. Biochim Biophys Acta. 1991 May 17;1092(3):350–357. doi: 10.1016/s0167-4889(97)90012-4. [DOI] [PubMed] [Google Scholar]
  23. Tisdale M. J. Biology of cachexia. J Natl Cancer Inst. 1997 Dec 3;89(23):1763–1773. doi: 10.1093/jnci/89.23.1763. [DOI] [PubMed] [Google Scholar]
  24. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., Tisdale M. Characterization of a cancer cachectic factor. Nature. 1996 Feb 22;379(6567):739–742. doi: 10.1038/379739a0. [DOI] [PubMed] [Google Scholar]
  25. WAALKES T. P., UDENFRIEND S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med. 1957 Nov;50(5):733–736. [PubMed] [Google Scholar]
  26. Wettenhall R. E., Cohen P. Isolation and characterisation of cyclic AMP-dependent phosphorylation sites from rat liver ribosomal protein S6. FEBS Lett. 1982 Apr 19;140(2):263–269. doi: 10.1016/0014-5793(82)80910-1. [DOI] [PubMed] [Google Scholar]
  27. de Groot R. P., den Hertog J., Vandenheede J. R., Goris J., Sassone-Corsi P. Multiple and cooperative phosphorylation events regulate the CREM activator function. EMBO J. 1993 Oct;12(10):3903–3911. doi: 10.1002/j.1460-2075.1993.tb06068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES